First quarter 2025 earnings call this is Ziyi Chen, China Healthcare Analyst Goldman Sachs. Before we kick off the session, I would like to highlight that this call strictly for clients Goldman Sachs ...

1 State Key Laboratory of Molecular ... in the ‘Guide for the Care and Use of Laboratory Animals’ and the National Research Council – ILAR, Revised 2011. The study was reviewed and approved by WuXi ...

State Key Laboratory of Food Science and Resources, School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu 214122, China ...

China’s WuXi AppTec, which a US legislative commission called the “Huawei equivalent for biotechnology”, has reported a surge in US business despite increased scrutiny from Washington ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

the State Department, and the Office of the Director of National Intelligence briefed senators on activity carried out by WuXi AppTec and others that was against the interests of US national security.

In doing so, WuXi AppTec (603259.SH ... least $23 billion in U.S. infrastructure in the next five years to ensure key drugs destined for U.S. patients will be made locally.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...